Document Type: Special Notice
Solicitation Number: 75N91019Q00116
Posted Date: 07/29/2019
Response Date: 08/09/2019
Classification Code: B529 - Special Studies/Analysis
NAICS Code: 611310 - Colleges, Universities, and Professional Schools

Contracting Office Address
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E128, Bethesda, MD 20892.

Description
National Cancer Institute (NCI), Division of Epidemiology and Genetics (DCEG), Radiation Epidemiology Branch (REB) plans to procure the services described below, on a sole source basis, from the University of California - Davis of 1850 Research Park Dr, Suite 300, Davis, CA, 95618-6153.

The response close date of this notice for this requirement is in accordance with FAR 5.203(a)(1). This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR 13.106-1(b)(1) using simplified acquisition procedures for commercial acquisitions. The North American Industry Classification System code is 611310 - Colleges, Universities, and Professional Schools.

OBJECTIVE

The aim of the procurement is to conduct a linkage between the Center for International Blood and Marrow Transplantation Research (CIBMTR), the California Cancer Registry (CCR) and vital statistics registry, and the California Patient Discharge Database (PDD) to obtain data on malignancies, treatment, selected non-cancer outcomes, selected patient demographic and clinical variables, vital status and cause of death, as specified below. As part of the linkage, residential histories of CIBMTR patients will be obtained to capture migration data out of the State of California.
SCOPE

The information obtained under this procurement will be used to 1) evaluate the completeness of the CIBMTR data. This includes both the ascertainment of patients who underwent HCT for treatment of hematologic malignancies by the CIBMTR and short- and long-term outcomes after HCT (cause-specific mortality, subsequent malignancies, cardiovascular disease and infections) as collected by the CIBMTR against registry data (gold standard); 2) conduct descriptive analyses of the use of HCT for treatment of hematologic malignancies (e.g., comparisons of the characteristics of hematologic malignancy patients who did and did not receive HCT; 3) describe the incidence of the above-mentioned short- and long-term outcomes among HCT-recipients and to compare this with the incidence of these outcomes among hematologic malignancy patients who have not undergone HCT.

The specific aims of this procurement are to:

1.1 Link the records for all hematologic malignancies from the California Cancer Registry (CCR) data from 1991 to 2016 with the vital statistics registry and the California Patient Discharge Database (PDD).
1.2 Link the CIBMTR data for patients who resided in California at the time of autologous or allogeneic HCT taking place in California during 1991 to 2016 (~32,000) with the CCR, vital statistics registry and PDD.
1.3 Obtain residential histories to determine date of migration out of California for patients who resided in California at the time of autologous or allogeneic HCT taking place in California during 1991 to 2016 (~32,000) through tracing with LexisNexis.

The unique qualifications of the University of California - Davis (UC Davis) to this procurement are: 1) the access to the necessary data, and 2) the established, unique expertise for conducting the necessary linkages (demonstrated by peer-reviewed publications) between the Central Cancer Registry (CCR) and the California Patient Discharge Database (PDD).

The CCR, maintained by the UC Davis, has a unified database of cancer data for the entire state of California that includes the specific variables required to conduct the linkage with both the CIBMTR file and the PDD database. Furthermore, the CCR data have already been linked with the state's vital statistics registry, and the CCR has an existing contract with LexisNexis to enable tracing of all CCR patients to evaluate whether they have emigrated from California during the study period. The UC Davis will provide the REB with a merged, linked datafile that is necessary for evaluating the completeness of late effects data in the CIBMTR. Leading studies of treatment-related subsequent malignancies and other late effects in this patient population is a high priority for the REB, building on the REB's long-standing expertise in this area of research. Evaluation of the robustness of the CIBMTR late effects data collection is critical for determining the optimal design for future studies in this research area. For the aforementioned reasons, UC Davis is the only known source to NCI that can complete this requirement.

All responses and questions shall be emailed to William Neal, Contracting Officer, via electronic mail at [email protected]. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must be registered and have valid certification in the System for Award Management (SAM) through SAM.gov. Reference: 75N91019Q00116 on all correspondence.

This notice is not a request for competitive quotation. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Responses must be received via electronic mail at [email protected] by 3:00 PM EST, on August 09, 2019.

Responses should include both the STATEMENT OF CAPABILITY and BUSINESS SIZE AND SOCIO-ECONOMIC STATUS information as explained below. This notice is to assist with determining sources only. If a solicitation is issued it will be announced at a later date, and all interested parties must respond to that solicitation announcement separately from the responses to this announcement.

REQUESTED INFORMATION: (1) STATEMENT OF CAPABILITY: Submit a brief description [ten (10) pages or less] that includes product specifications. Include past experience with performing this type of service for Government (Federal or State) agencies, or for a private medical facility. Please indicate your address (2) BUSINESS SIZE AND SOCIO-ECONOMIC STATUS: (a) Indicate whether your business is large or small (b) If small, indicate if your firm qualifies as a small, emerging business, or small disadvantaged business (c) If disadvantaged, specify under which disadvantaged group and if your firm is certified under Section 8(a) of the Small Business Act (d) Indicate if your firm is a certified Hub-zone firm (e) Indicate if your firm is a woman-owned or operated business (f) Indicate if your firm is a certified Service-Disabled Veteran Owned Small Business (SDVOSB) or Veteran Owned Small Business (VOSB)(g) Include the DUNS number of your firm. (h) State whether your firm is registered with SAM System for Award Management www.sam.gov/. If not, please NOTE: any future solicitation can only be awarded to a contractor who is registered in SAM.